跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,022 条关于
“UOB Kay Hian”
全部
6,022
临床试验
3,935
药物
687
机构
85
资讯
1,315
上个月
Analysts Maintain Buy Ratings on Sino Biopharmaceutical with Strong Upside Potential
18天前
Senate Unanimously Passes Kay Hagan Tick Reauthorization Act as Lyme Cases Hit Record Highs
去年
Gildeuretinol Shows Promise in Slowing Stargardt Disease Progression
去年
Gildeuretinol Shows Promise in TEASE Trials for Stargardt Disease
11个月前
AdvanCell Appoints Alpha Therapy Pioneer Andrew Kay as Board Chair to Lead PSMA-Targeted Radiopharmaceutical Development
去年
Novel Compound SHP1705 Targets Circadian Clock to Combat Aggressive Glioblastoma
去年
Gildeuretinol Receives FDA Fast Track and Rare Pediatric Disease Designations for Stargardt Disease
去年
Gildeuretinol Receives FDA Fast Track and Rare Pediatric Disease Designations for Stargardt Disease
12个月前
FDA Clears HDT Bio's First-in-Class HDT-321 for Crimean-Congo Hemorrhagic Fever Prevention
去年
Alkeus Pharmaceuticals Presents Positive Data on Gildeuretinol for Geographic Atrophy and Stargardt Disease
第 1 页,共 132 页
上一页
下一页